Le Lézard
Classified in: Health
Subjects: CCA, FVT

Genomma Lab Announces Third Quarter 2021 Financial Results Call and Webcast


MEXICO CITY, Oct. 14, 2021 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its Third Quarter 2021 results on Wednesday, October 27, 2021 after the Mexican Market (BMV) close.

Presenters
Mr. Jorge Luis Brake, Chief Executive Officer
Mr. Antonio Zamora, Chief Financial Officer

Date
Thursday, October 28, 2021

Time
11:00 a.m. ET / 10:00 a.m. CST (Mexico City Time)

Dial-in
+1 877-407-0784 (U.S.)
+1 201-689-8560 (International)

If you would prefer to receive a call rather than dialing in, please register via the following link. Please use this option 10-15 minutes prior to conference call start time: Call Me Link

Participants who do not wish to be interrupted to have their information gathered may have provider dial out to them by clicking on the above link, filling in the information, and pressing the green phone button at the bottom. The phone number provided will be automatically called and connected to the conference without any interruption to the participant.

(Please note: Participants will be joined directly to the conference and will hear hold music until the call begins. No confirmation message will be played when joined.)

Webcast
Third Quarter 2021 Results

Replay
+1 844-512-2921 (U.S.)
+1 412-317-6671 (International)
Replay ID: 13723981
**Available until November 4, 2021

About Genomma Lab Internacional
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Genomma Lab relies on the combination of a successful new product development process, a consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM).

Contact:
Investor Relations
T. +52 (55) 5081 0000
[email protected]

 

SOURCE Genomma Lab Internacional, S.A.B. de C.V.


These press releases may also interest you

at 20:10
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...

at 19:20
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

at 18:50
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....

at 18:46
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

at 18:42
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...



News published on and distributed by: